28 June 2022>: Clinical Research
Impact of a Rehabilitation Program on the Change in Components of Body Mass of the Upper and Lower Limbs in People After Ischemic Stroke
Grzegorz Przysada 1ACDF , Justyna Leszczak 2ABEF* , Joanna Baran 2CDE , Andżelina Wolan-Nieroda 2BDF , Bogumiła Pniak 3CDE , Viliam Knap 4BDF , Mariusz Drużbicki 2ADF , Agnieszka Guzik 2ADEDOI: 10.12659/MSM.936397
Med Sci Monit 2022; 28:e936397
Table 8 The effect of rehabilitation on the amount of muscle mass at 2 to 3 and 4 to 6 months after stroke.
Time after stroke | Side of paresis | Exam | N | Mean median* | SDQ1–Q3* | p | Mean median* | SDQ1–Q3* | p | Mean median* | SDQ1–Q3* | p | Mean median* | SDQ1–Q3* | p | Mean median* | SDQ1–Q3* | p |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PMM | PMM right lower limb | PMM left lower limb | PMM right arm | PMM left arm | ||||||||||||||
2–3 months | Left | Exam I | 6 | 68.81 | 3.48 | 0.074*** | 40.32 | 1.93 | 0.603*** | 41.87 | 4.39 | 0.289*** | 42.95* | 39.29–43.59* | 0.345** | 41.73 | 3.38 | 0.145*** |
Exam II | 6 | 74.47 | 8.66 | 41.11 | 3.89 | 41.34 | 4.06 | 42.33* | 40.35–43.75* | 41.96 | 3.28 | |||||||
Right | Exam I | 6 | 67.44 | 3.44 | 0.240*** | 39.50 | 1.78 | 0.862*** | 39.46 | 3.52 | 0.920*** | 41.62 | 4.02 | 0.967*** | 42.49 | 4.99 | 0.779*** | |
Exam II | 6 | 72.68 | 8.32 | 39.18 | 4.01 | 39.44 | 3.46 | 41.63 | 4.56 | 42.46 | 4.85 | |||||||
2–3 months | Left | Exam II | 6 | 74.47 | 8.66 | 0.459*** | 41.11 | 3.89 | 0.755*** | 41.34 | 4.06 | 0.681*** | 41.59 | 3.31 | 0.555*** | 41.96 | 3.28 | 0.683*** |
Exam III | 6 | 69.69 | 13.70 | 40.31 | 3.86 | 40.30 | 3.74 | 43.00 | 3.98 | 43.10 | 4.46 | |||||||
Right | Exam II | 6 | 72.68 | 8.32 | 0.255*** | 39.18 | 4.01 | 0.560*** | 39.44 | 3.46 | 0.596*** | 41.63 | 4.56 | 0.909*** | 42.46 | 4.85 | 0.631*** | |
Exam III | 6 | 83.48 | 23.99 | 40.40 | 3.37 | 40.44 | 3.34 | 41.32 | 3.04 | 41.11 | 2.81 | |||||||
4–6 months | Left | Exam I | 7 | 72.47 | 5.31 | 0.309*** | 43.10 | 1.53 | 0.064*** | 40.12* | 35.76–42.44* | 0.893** | 41.30* | 40.35–43.37* | 0.225** | 41.02 | 3.53 | 0.511*** |
Exam II | 7 | 69.94 | 7.15 | 39.79 | 3.79 | 40.37* | 37.79–42.44* | 40.87* | 37.84–42.31* | 40.88 | 3.36 | |||||||
Right | Exam I | 1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
Exam II | 1 | – | – | – | – | – | – | – | – | – | – | |||||||
4–6 months | Left | Exam II | 7 | 71.38* | 61.84–72.67* | 0.735** | 39.79 | 3.79 | 0.451*** | 39.81 | 3.59 | 0.371*** | 40.37 | 3.03 | 0.222*** | 40.88 | 3.36 | 0.743*** |
Exam III | 7 | 65.84* | 62.53–80.98* | 41.03 | 3.51 | 41.35 | 3.68 | 42.58 | 2.95 | 41.42 | 3.33 | |||||||
Right | Exam II | 1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
Exam III | 1 | – | – | – | – | – | – | – | – | – | – | |||||||
* Median (Q1–Q3); ** Wilcoxon test; *** T-test. |